-
Product Insights
NewGenital Herpes – Drugs In Development, 2024
Empower your strategies with our Genital Herpes – Drugs In Development, 2024 report and make more profitable business decisions. Genital herpes is a common sexually transmitted infection that affects both men and women. Genital herpes is caused by the herpes simplex virus (HSV). Symptoms include decreased appetite; fever; general sick feeling (malaise); muscle aches in the lower back, buttocks, thighs, or knees; and swollen and tender lymph nodes in the groin during an outbreak. Treatment includes antiviral medications. The Genital Herpes...
-
Product Insights
NewNeisseria meningitidis Infections – Drugs In Development, 2024
Empower your strategies with our Neisseria meningitidis Infections – Drugs In Development, 2024 report and make more profitable business decisions. Neisseria Meningitidis is a severe bacterial infection of the bloodstream and meninges (a thin lining covering the brain and spinal cord). Symptoms include fever, neck stiffness, joint pain, nausea, confusion and drowsiness. Risk factors include age, smoking, mucosal lesions, overcrowding, climatic conditions such as dry seasons or prolonged drought and dust storms and concomitant respiratory infections. The Neisseria meningitidis Infections drugs...
-
Product Insights
NewSystemic Candidiasis – Drugs In Development, 2024
Empower your strategies with our Systemic Candidiasis – Drugs In Development, 2024 report and make more profitable business decisions. Systemic candidiasis encompasses a range of yeast infections resulting from various species of Candida, presenting a severe threat that can impact diverse areas of the body such as the blood, heart, brain, eyes, bones, and other organs. While there are over 200 Candida species, five specific types contribute to 90% of systemic candidiasis cases. The primary manifestation of this invasive yeast infection...
-
Product Insights
NewAnthrax – Drugs In Development, 2024
Empower your strategies with our Anthrax – Drugs In Development, 2024 report and make more profitable business decisions. Anthrax is a serious infectious disease caused by Bacillus anthracis. Signs and symptoms include nausea, vomiting, abdominal pain, headache, loss of appetite, fever, severe bloody diarrhea in the later stages of the disease, sore throat, and difficulty swallowing. Risk factors include illegal intravenous drug use, exposure to animal skins, and working in veterinary medicine, especially dealing with livestock. The Anthrax drugs in development...
-
Product Insights
NewChagas Disease (American Trypanosomiasis) – Drugs In Development, 2024
Empower your strategies with our Chagas Disease (American Trypanosomiasis) – Drugs In Development, 2024 report and make more profitable business decisions. Chagas disease, or American trypanosomiasis is a vector-borne anthropozoonosis caused by the protozoan parasite Trypanosoma cruzi. Symptoms include swelling at the infection site, fever, fatigue, body aches, loss of appetite, nausea, diarrhea or vomiting, and swollen glands. Treatment includes antiparasitic medications. The Chagas Disease (American Trypanosomiasis) drugs in development market research report provide comprehensive information on the therapeutics under development...
-
Product Insights
NewGenital Warts (Condylomata Acuminata) – Drugs In Development, 2024
Empower your strategies with our Genital Warts (Condylomata Acuminata) – Drugs In Development, 2024 report and make more profitable business decisions. Genital warts (condyloma acuminatum) are a sexually transmitted infection caused by the human papillomavirus (HPV) types 6 and 11. It is spread by skin-to-skin contact, usually during sex. The warts present in clusters or separately and can be found in the genital or anal area. Genital warts are typically painless but can cause itching, discomfort, or bleeding. Treatments may include...
-
Product Insights
NewPulmonary Tuberculosis – Drugs In Development, 2024
Empower your strategies with our Pulmonary Tuberculosis – Drugs In Development, 2024 report and make more profitable business decisions. Pulmonary tuberculosis (TB) is an infectious respiratory disease caused by Mycobacterium tuberculosis, capable of spreading to other organs. The bacterium is highly contagious, transmitted through air droplets from coughs or sneezes of infected individuals. Initial infection, known as primary TB, may be asymptomatic. When symptoms manifest, they encompass breathing difficulties, chest pain, cough with mucus, blood-tinged sputum, night sweats, fatigue, fever, weight...
-
Product Insights
NewNorovirus Infections – Drugs In Development, 2024
Empower your strategies with our Norovirus Infections – Drugs In Development, 2024 report and make more profitable business decisions. Noroviruses are nonenveloped, positive-sense, single-stranded RNA viruses belonging to the Caliciviridae viral family. It is a highly contagious virus causing gastroenteritis, leading to stomach and intestinal inflammation. A common cause of outbreaks of diarrhea and vomiting in schools, cruise ships, hospitals, and community gatherings, it's nicknamed the "winter vomiting bug" due to prevalence in colder months. Symptoms encompass nausea, vomiting, diarrhea, and...
-
Product Insights
NewPolyomavirus Infections – Drugs In Development, 2024
Empower your strategies with our Polyomavirus Infections – Drugs In Development, 2024 report and make more profitable business decisions. Polyomaviruses, a family of small DNA viruses, pose potential threats to human health. Among them, the BK virus (BKV) and JC virus (JCV) are known to infect humans, with implications for those with weakened immune systems. While these viruses can circulate without symptoms in the general population, immunocompromised individuals face complications. BKV may induce nephropathy or cystitis, particularly in organ transplant recipients....
-
Product Insights
NewSkin And Skin Structure Infections (SSSI) Caused By Bacteria – Drugs In Development, 2024
Empower your strategies with our Skin And Skin Structure Infections (SSSI) Caused By Bacteria – Drugs In Development, 2024 report and make more profitable business decisions. Skin and Skin Structure Infections (SSSIs) caused by bacteria encompass a spectrum of infections affecting the skin and underlying tissues, varying from mild to severe and instigated by diverse bacteria. Notable culprits include Staphylococcus aureus, including methicillin-resistant strains (MRSA), Streptococcus pyogenes (group A Streptococcus), and other streptococcal species. SSSI can manifest as cellulitis, erysipelas, impetigo,...